Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,108
archived clinical trials in
Lupus

Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
Long Beach, CA
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
Upland, CA
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
Upland, CA
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
Brandon, FL
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
Brandon, FL
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
Clearwater, FL
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
Miami Lakes, FL
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
Orlando, FL
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
Tampa, FL
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
Granger, IN
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
Granger, IN
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
Baton Rouge, LA
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
Lansing, MI
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
Lansing, MI
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
Lansing, MI
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
Lansing, MI
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
Brooklyn, NY
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
Great Neck, NY
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
Great Neck, NY
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
New York, NY
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
Charlotte, NC
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
Hershey, PA
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
Hershey, PA
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
Wyomissing, PA
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
Wyomissing, PA
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
Houston, TX
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
Houston, TX
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Vitamin D3 in Systemic Lupus Erythematosus
Effect of Vitamin D3 on the IFN Alpha Signature in Patients With Systemic Lupus Erythematosus (ALE02)
Status: Enrolling
Updated:  11/7/2015
University of Alabama
mi
from
Birmingham, AL
Vitamin D3 in Systemic Lupus Erythematosus
Effect of Vitamin D3 on the IFN Alpha Signature in Patients With Systemic Lupus Erythematosus (ALE02)
Status: Enrolling
Updated: 11/7/2015
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Vitamin D3 in Systemic Lupus Erythematosus
Effect of Vitamin D3 on the IFN Alpha Signature in Patients With Systemic Lupus Erythematosus (ALE02)
Status: Enrolling
Updated:  11/7/2015
University of California at San Francisco
mi
from
San Francisco, CA
Vitamin D3 in Systemic Lupus Erythematosus
Effect of Vitamin D3 on the IFN Alpha Signature in Patients With Systemic Lupus Erythematosus (ALE02)
Status: Enrolling
Updated: 11/7/2015
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Vitamin D3 in Systemic Lupus Erythematosus
Effect of Vitamin D3 on the IFN Alpha Signature in Patients With Systemic Lupus Erythematosus (ALE02)
Status: Enrolling
Updated:  11/7/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Vitamin D3 in Systemic Lupus Erythematosus
Effect of Vitamin D3 on the IFN Alpha Signature in Patients With Systemic Lupus Erythematosus (ALE02)
Status: Enrolling
Updated: 11/7/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Vitamin D3 in Systemic Lupus Erythematosus
Effect of Vitamin D3 on the IFN Alpha Signature in Patients With Systemic Lupus Erythematosus (ALE02)
Status: Enrolling
Updated:  11/7/2015
Feinstein Institute for Medical Research
mi
from
Manhassett, NY
Vitamin D3 in Systemic Lupus Erythematosus
Effect of Vitamin D3 on the IFN Alpha Signature in Patients With Systemic Lupus Erythematosus (ALE02)
Status: Enrolling
Updated: 11/7/2015
Feinstein Institute for Medical Research
mi
from
Manhassett, NY
Click here to add this to my saved trials
Vitamin D3 in Systemic Lupus Erythematosus
Effect of Vitamin D3 on the IFN Alpha Signature in Patients With Systemic Lupus Erythematosus (ALE02)
Status: Enrolling
Updated:  11/7/2015
University of Rochester
mi
from
Rochester, NY
Vitamin D3 in Systemic Lupus Erythematosus
Effect of Vitamin D3 on the IFN Alpha Signature in Patients With Systemic Lupus Erythematosus (ALE02)
Status: Enrolling
Updated: 11/7/2015
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Vitamin D3 in Systemic Lupus Erythematosus
Effect of Vitamin D3 on the IFN Alpha Signature in Patients With Systemic Lupus Erythematosus (ALE02)
Status: Enrolling
Updated:  11/7/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Vitamin D3 in Systemic Lupus Erythematosus
Effect of Vitamin D3 on the IFN Alpha Signature in Patients With Systemic Lupus Erythematosus (ALE02)
Status: Enrolling
Updated: 11/7/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Vitamin D3 in Systemic Lupus Erythematosus
Effect of Vitamin D3 on the IFN Alpha Signature in Patients With Systemic Lupus Erythematosus (ALE02)
Status: Enrolling
Updated:  11/7/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Vitamin D3 in Systemic Lupus Erythematosus
Effect of Vitamin D3 on the IFN Alpha Signature in Patients With Systemic Lupus Erythematosus (ALE02)
Status: Enrolling
Updated: 11/7/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Vitamin D3 in Systemic Lupus Erythematosus
Effect of Vitamin D3 on the IFN Alpha Signature in Patients With Systemic Lupus Erythematosus (ALE02)
Status: Enrolling
Updated:  11/7/2015
Medical University of South Carolina
mi
from
Charleston, SC
Vitamin D3 in Systemic Lupus Erythematosus
Effect of Vitamin D3 on the IFN Alpha Signature in Patients With Systemic Lupus Erythematosus (ALE02)
Status: Enrolling
Updated: 11/7/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Torrance, CA
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Orlando, FL
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Boston, MA
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Great Neck, NY
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Columbus, OH
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Memphis, TN
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
El Paso, TX
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Boston, MA
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Great Neck, NY
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Columbus, OH
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
Memphis, TN
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
Clinical Research Facility
mi
from
El Paso, TX
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated:  11/12/2015
mi
from
La Plata,
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long-Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects With Lupus Nephritis
Status: Enrolling
Updated: 11/12/2015
mi
from
La Plata,
Click here to add this to my saved trials
The CARRA Registry
The CARRA Registry
Status: Enrolling
Updated:  11/16/2015
Duke Clinical Research Institute
mi
from
Durham, NC
The CARRA Registry
The CARRA Registry
Status: Enrolling
Updated: 11/16/2015
Duke Clinical Research Institute
mi
from
Durham, NC
Click here to add this to my saved trials
Reducing Depressive Symptoms in Systemic Lupus Erythematosus
Reducing Depressive Symptoms in Systemic Lupus Erythematosus
Status: Enrolling
Updated:  11/30/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Reducing Depressive Symptoms in Systemic Lupus Erythematosus
Reducing Depressive Symptoms in Systemic Lupus Erythematosus
Status: Enrolling
Updated: 11/30/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus
A Double-Blind, Placebo-Controlled Dose Escalation Study of the Administration of Multiple Intravenous Doses of RSLV-132 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/8/2015
Clinical Research of West Florida
mi
from
Clearwater, FL
Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus
A Double-Blind, Placebo-Controlled Dose Escalation Study of the Administration of Multiple Intravenous Doses of RSLV-132 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/8/2015
Clinical Research of West Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus
A Double-Blind, Placebo-Controlled Dose Escalation Study of the Administration of Multiple Intravenous Doses of RSLV-132 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/8/2015
West Michigan Rheumatology
mi
from
Grand Rapids, MI
Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus
A Double-Blind, Placebo-Controlled Dose Escalation Study of the Administration of Multiple Intravenous Doses of RSLV-132 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/8/2015
West Michigan Rheumatology
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus
A Double-Blind, Placebo-Controlled Dose Escalation Study of the Administration of Multiple Intravenous Doses of RSLV-132 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/8/2015
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus
A Double-Blind, Placebo-Controlled Dose Escalation Study of the Administration of Multiple Intravenous Doses of RSLV-132 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/8/2015
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Click here to add this to my saved trials
Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus
A Double-Blind, Placebo-Controlled Dose Escalation Study of the Administration of Multiple Intravenous Doses of RSLV-132 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  12/8/2015
Metroplex Clinical Research
mi
from
Dallas, TX
Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus
A Double-Blind, Placebo-Controlled Dose Escalation Study of the Administration of Multiple Intravenous Doses of RSLV-132 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 12/8/2015
Metroplex Clinical Research
mi
from
Dallas, TX
Click here to add this to my saved trials
Magnetic Resonance Spectroscopy, Perfusion and Diffusion Tensor Imaging in Neuropsychiatric Lupus
Status: Enrolling
Updated:  12/10/2015
University of Michigan Hospital
mi
from
Ann Arbor, MI
Magnetic Resonance Spectroscopy, Perfusion and Diffusion Tensor Imaging in Neuropsychiatric Lupus
Status: Enrolling
Updated: 12/10/2015
University of Michigan Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric Lupus
Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric Lupus
Status: Enrolling
Updated:  12/10/2015
University of Michigan Health Systems
mi
from
Ann Arbor, MI
Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric Lupus
Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric Lupus
Status: Enrolling
Updated: 12/10/2015
University of Michigan Health Systems
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus
Vitamin D3 Effects on Immune Function in Pediatric Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/15/2015
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus
Vitamin D3 Effects on Immune Function in Pediatric Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/15/2015
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials